Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced the pricing of its previously announced ...
Merck , known as MSD outside of the United States and Canada, and Cidara Therapeutics, Inc. ("Cidara"), a biotechnology company developing drug-Fc conjugate (DFC) therapeutics, today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback